Usefulness of droplet digital PCR and Sanger sequencing for detection of FGFR3 mutation in bladder cancer.

Urol Oncol 2019 12 31;37(12):907-915. Epub 2019 Jul 31.

Medical University of Lodz, Chair of Laboratoty and Clinical Genetics, Department of Clinical Genetics, Lodz 92-213, Poland.

Objective: The purpose of our research was to determine the usefulness of different methods for detecting Y373C mutation of gene FGFR3.

Patients And Methods Total: 138 primary bladder cancer patients (71cases G1 and 67 cases G2-G3) were included in the study. Tumor tissue and urine samples were collected and kept frozen until the isolation of DNA. Sanger sequencing was applied for detecting mutation in cancer and ddPCR was utilized for urine assessment.

Results: ddPCR appears to be more effective and it identified FGFR3 mutation (Y373C) in urinary sediment in 20.3% of cases whereas Sanger sequencing did in 15.5%. Only in 8/39 (20.5%) cases the mutation was observed both in urine and tissue. In 12/39 (30.8%) cases (5G1 and 7 G2-G3) we did not detect any FGFR3 mutation in urine although it was confirmed by sequencing. We only found mutation in urine in 20/39 cases (15 G1, 5 G2-G3) (51.3%). The correlation between the presence of FGFR3 mutations and better survival was confirmed. The Log-Rank test indicates a significant difference in the likelihood of survival for patients with the FGFR3 mutation but without recurrence (Cox's F-test P = 0.17006; Log-Rank Test P = 0.00059).

Conclusion: ddPCR appeared to be more sensitive method for detection FGFR3 gene mutation particularly for detecting low levels of tumor DNA amongst a large excess of nontumor DNA. It is significant as the implementation of such markers into routine practice could be beneficial. The prospective study in larger cohort is needed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2019.06.010DOI Listing
December 2019

Publication Analysis

Top Keywords

fgfr3 mutation
16
sanger sequencing
12
mutation
9
log-rank test
8
mutation urine
8
detection fgfr3
8
bladder cancer
8
cases g2-g3
8
fgfr3
6
urine
5
cases
5
urine 20/39
4
confirmed sequencing
4
detect fgfr3
4
urine confirmed
4
sequencing mutation
4
513% correlation
4
survival confirmed
4
fgfr3 mutations
4
mutations better
4

Similar Publications